Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Irradiated DLI + High-dose IL-2 in Melanoma and RCC
NCT01925118Phase 2Terminated
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2013
- Primary completion
- May 2015
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of irradiated donor lymphocyte infusion in Malignant Melanoma (MM), renal cell carcinoma (RCC), sponsored by Seoul National University Hospital. Started Aug 2013; status: terminated.
02
Drugs
irradiated donor lymphocyte infusion
03
Conditions
Malignant Melanoma (MM)renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01925118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01925118.